SonnoMed

SomnoMed is an Australian-listed medical device company focused on oral appliance therapy for obstructive sleep apnea and related sleep-disordered breathing. The company develops, manufactures, and commercializes custom mandibular advancement devices under the SomnoDent brand, serving patients through sleep physicians and dental sleep medicine providers. Its products are marketed as alternatives or complements to CPAP for appropriate patients with obstructive sleep apnea, and the company operates across North America, Europe, Asia-Pacific, and other international markets. SomnoMed also has a technology-enabled device initiative called Rest Assure, designed to add compliance monitoring to oral appliances. The business is fully commercial, with more than one million patients reportedly treated globally and revenue generated from device sales and associated sleep-treatment services.